High-Density Lipoprotein Subspecies in Health and Human Disease: Focus on Type 2 Diabetes
By: W. Sean Davidson and Amy S. Shah
References
- Gordon T Castelli WP Hjortland MC Kannel WB Dawber TR High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study Am J Med 1977 May 62 5 707 14
- Sharrett AR Ballantyne CM Coady SA .; Atherosclerosis Risk in Communities Study Group Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study Circulation 2001 Sep 4 104 10 1108 13
- Gordon DJ Probstfield JL Garrison RJ High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies Circulation 1989 Jan 79 1 8 15
- HPS2-THRIVE Collaborative Group HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment Eur Heart J 2013 May 34 17 1279 91
- Barter PJ Caulfield M Eriksson M .; ILLUMINATE Investigators Effects of torcetrapib in patients at high risk for coronary events N Engl J Med 2007 Nov 22 357 21 2109 22
- AIM-HIGH Investigators Boden WE Probstfield JL Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy N Engl J Med 2011 Dec 15 365 24 2255 67
- Schwartz GG Olsson AG Abt M .; dal-OUTCOMES Investigators Effects of dalcetrapib in patients with a recent acute coronary syndrome N Engl J Med 2012 Nov 29 367 22 2089 99
- Ferri N Corsini A Sirtori CR Ruscica M Present therapeutic role of cholesteryl ester transfer protein inhibitors Pharmacol Res 2018 Feb 128 29 41
- HPS2-THRIVE Collaborative Group Landray MJ Haynes R Effects of extended-release niacin with laropiprant in high-risk patients N Engl J Med 2014 Jul 17 371 3 203 12
- Voight BF Peloso GM Orho-Melander M Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study Lancet 2012 Aug 11 380 9841 572 80
- Castro GR Fielding CJ Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein Biochemistry 1988 Jan 12 27 1 25 9
- Rohatgi A High-Density Lipoprotein Function Measurement in Human Studies: Focus on Cholesterol Efflux Capacity Prog Cardiovasc Dis 2015 Jul–Aug 58 1 32 40
- Rye KA High density lipoprotein structure, function, and metabolism: a new Thematic Series J Lipid Res 2013 Aug 54 8 2031 3
- The Davidson/Shah Lab {Internet] Cincinnatti, OH University of Cincinnatti c2015 HDL Proteome Watch; 2015 Aug 14 {cited 2018 Oct10]. Available from: http://homepages.uc.edu/~davidswm/HDLproteome.html
- Davidson WS Silva RA Chantepie S Lagor WR Chapman MJ Kontush A Proteomic analysis of defined HDL subpopulations reveals particle-specific protein clusters: relevance to antioxidative function Arterioscler Thromb Vasc Biol 2009 Jun 29 6 870 6
- Gordon SM Deng J Lu LJ Davidson WS Proteomic characterization of human plasma high density lipoprotein fractionated by gel filtration chromatography J Proteome Res 2010 Oct 1 9 10 5239 49
- Raper J Fung R Ghiso J Nussenzweig V Tomlinson S Characterization of a novel trypanosome lytic factor from human serum Infect Immun 1999 Apr 67 4 1910 6
- Melchior JT Street SE Andraski AB Apolipoprotein A-II alters the proteome of human lipoproteins and enhances cholesterol efflux from ABCA1 J Lipid Res 2017 Jul 58 7 1374 85
- Chandra A Rohatgi A The role of advanced lipid testing in the prediction of cardiovascular disease Curr Atheroscler Rep 2014 Mar 16 3 394
- Bakogianni MC Kalofoutis CA Skenderi KI Kalofoutis AT Clinical evaluation of plasma high-density lipoprotein subfractions (HDL2, HDL3) in non-insulin-dependent diabetics with coronary artery disease J Diabetes Complications 2001 Sep–Oct 15 5 265 9
- Russo GT Giandalia A Romeo EL Markers of Systemic Inflammation and Apo-AI Containing HDL Subpopulations in Women with and without Diabetes Int J Endocrinol 2014 2014 607924
- Amor AJ Catalan M Pérez A Nuclear magnetic resonance lipoprotein abnormalities in newly-diagnosed type 2 diabetes and their association with preclinical carotid atherosclerosis Atherosclerosis 2016 Apr 247 161 9
- Garvey WT Kwon S Zheng D Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance Diabetes 2003 Feb 52 2 453 62
- Mora S Otvos JD Rosenson RS Pradhan A Buring JE Ridker PM Lipoprotein particle size and concentration by nuclear magnetic resonance and incident type 2 diabetes in women Diabetes 2010 May 59 5 1153 60
- Davidson WS Heink A Sexmith H Obesity is associated with an altered HDL subspecies profile among adolescents with metabolic disease J Lipid Res 2017 Sep 58 9 1916 23
- Gordon SM Davidson WS Urbina EM The effects of type 2 diabetes on lipoprotein composition and arterial stiffness in male youth Diabetes 2016 Jul 65 7 2100
- Hiukka A Leinonen E Jauhiainen M Long-term effects of fenofibrate on VLDL and HDL subspecies in participants with type 2 diabetes mellitus Diabetologia 2007 Oct 50 10 2067 75
- Soedamah-Muthu SS Colhoun HM Thomason MJ .; CARDS Investigators The effect of atorvastatin on serum lipids, lipoproteins and NMR spectroscopy defined lipoprotein subclasses in type 2 diabetic patients with ischaemic heart disease Atherosclerosis 2003 Apr 167 2 243 55
- Azar M Lyons TJ Alaupovic P Apolipoprotein-defined and NMR lipoprotein subclasses in the veterans affairs diabetes trial J Diabetes Complications 2013 Nov–Dec 27 6 627 32
- Davidson WS Inge TH Sexmith H Weight loss surgery in adolescents corrects high-density lipoprotein subspecies and their function Int J Obes (Lond) 2017 Jan 41 1 83 9
- Mendivil CO Furtado J Morton AM Wang L Sacks FM Novel Pathways of Apolipoprotein A-I Metabolism in High-Density Lipoprotein of Different Sizes in Humans Arterioscler Thromb Vasc Biol 2016 Jan 36 1 156 65
- Goldberg IJ Clinical review 124: Diabetic dyslipidemia: causes and consequences J Clin Endocrinol Metab 2001 Mar 86 3 965 71
- Awadallah S Madkour M Hamidi RA Plasma levels of Apolipoprotein A1 and Lecithin:Cholesterol Acyltransferase in type 2 diabetes mellitus: Correlations with haptoglobin phenotypes Diabetes Metab Syndr 2017 Dec 11 Suppl 2 S543 S546
- Nakhjavani M Esteghamati A Esfahanian F Ghanei A Rashidi A Hashemi S HbA1c negatively correlates with LCAT activity in type 2 diabetes Diabetes Res Clin Pract 2008 Jul 81 1 38 41
- Fournier N Myara I Atger V Moatti N Reactivity of lecithin-cholesterol acyl transferase (LCAT) towards glycated high-density lipoproteins (HDL) Clin Chim Acta 1995 Jan 31 234 1–2 47 61
- Sorrentino SA Besler C Rohrer L Endothelial-vasoprotective effects of high-density lipoprotein are impaired in patients with type 2 diabetes mellitus but are improved after extended-release niacin therapy Circulation 2010 Jan 5 121 1 110 22
- Perségol L Vergès B Foissac M Gambert P Duvillard L Inability of HDL from type 2 diabetic patients to counteract the inhibitory effect of oxidised LDL on endothelium-dependent vasorelaxation Diabetologia 2006 Jun 49 6 1380 6
- Vaisar T Couzens E Hwang A Type 2 diabetes is associated with loss of HDL endothelium protective functions PLoS One 2018 Mar 15 13 3 e0192616
- Asztalos BF Tani M Schaefer EJ Metabolic and functional relevance of HDL subspecies Curr Opin Lipidol 2011 Jun 22 3 176 85
- Asztalos BF de la Llera-Moya M Dallal GE Horvath KV Schaefer EJ Rothblat GH Differential effects of HDL subpopulations on cellular ABCA1- and SR-BI-mediated cholesterol efflux J Lipid Res 2005 Oct 46 10 2246 53
- Tan HC Tai ES Sviridov D Relationships between cholesterol efflux and high-density lipoprotein particles in patients with type 2 diabetes mellitus J Clin Lipidol 2011 Nov–Dec 5 6 467 73
- de Beer MC Durbin DM Cai L Jonas A de Beer FC van der Westhuyzen DR Apolipoprotein A-I conformation markedly influences HDL interaction with scavenger receptor BI J Lipid Res 2001 Feb 42 2 309 13
- Umaerus M Rosengren B Fagerberg B Hurt-Camejo E Camejo G HDL2 interferes with LDL association with arterial proteoglycans: a possible athero-protective effect Atherosclerosis 2012 Nov 225 1 115 20
- Heffron SP Singh A Zagzag J Laparoscopic gastric banding resolves the metabolic syndrome and improves lipid profile over five years in obese patients with body mass index 30–40 kg/m2 Atherosclerosis 2014 Nov 237 1 183 90
- Haase CL Tybjarg-Hansen A Nordestgaard BG Frikke-Schmidt R HDL Cholesterol and Risk of Type 2 Diabetes: A Mendelian Randomization Study Diabetes 2015 Sep 64 9 3328 33
- von Eckardstein A Widmann C High-density lipoprotein, beta cells, and diabetes Cardiovasc Res 2014 Aug 1 103 3 384 94
- Masson W Lobo M Siniawski D Therapy with cholesteryl ester transfer protein (CETP) inhibitors and diabetes risk Diabetes Metab. 2018 Feb 20 pii: S1262-3636(18)30045-4
DOI: https://doi.org/10.14797/mdcj-15-1-55 | Journal eISSN: 1947-6108
Language: English
Page range: 55 - 61
Published on: Jan 1, 2019
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services
© 2019 W. Sean Davidson, Amy S. Shah, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.